Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
11018630 | Digestive and Liver Disease | 2018 | 6 Pages |
Abstract
The overall prognosis of patients with esophageal cancer has improved in recent decades due to surgical and medical progress, but overall survival remains poor. Better patient selection and tailored treatment are needed. Different prognostic factors linked with the patient, tumoral characteristics and treatment with curative intent have been identified and are the purpose of this review. Tumor detection at an earlier stage, the advent of new molecules and therapeutic combinations, and the centralization of management in high-volume centers should help to improve the prognosis of esophageal cancer. Improved imaging techniques and a better prediction strategy should guide future treatments.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Véronique Vendrely, Vincent Launay, Haythem Najah, Denis Smith, Denis Collet, Caroline Gronnier,